Latest News

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) beat Wall Street’s revenue expectations in Q3 2026, with revenue up 6.8% year on year to $8.3 billion...

Digital transformation consultancy Grid Dynamics (NASDAQ:GDYN) beat Wall Street’s revenue expectations in Q3 2026, with revenue rising 9.7% year on year to $...

Mullen Group's strong financial growth and regular dividend payouts could make it an attractive choice for investors seeking monthly passive income.

Wheaton's falling share price offers a fresh look at a business that earns from precious metals without operating the mines.

Cost cuts and EV growth offset regional headwinds as Stellantis targets 2027 profitability.

AFFO grew 5.4% as portfolio occupancy hit 100% and development pipeline expanded.

Record revenue and margin expansion drove returns above 16% for the sixth straight quarter.

Mortgage rate surge pressured home closings and buyer demand in Q3.

Gold prices surged 22.7% year-over-year, but diesel and tariff headwinds pressured costs.

Skouries and McIlvenna Bay ramp-ups delayed; 2026 production guidance cut.

Island Gold hit record output while project timelines shifted due to ground conditions.

Adjusted EBITDA surged 55% as production volumes and selling prices climbed.

FFO surged 42% year-over-year as occupancy climbed and debt became fully fixed-rate.

Olympic Steel integration drives record synergy realization and margin expansion.

Management is shifting capital away from buybacks toward spectrum auctions, betting network capacity matters more than shareholder returns.

Infrastructure equipment supplier SPX Technologies (NYSE:SPXC) met Wall Street’s revenue expectations in Q3 2026, with revenue up 20.5% year on year to $714....

It's not only the company's success in beating expectations that is helping the stock to gain altitude today.

Cloud computing and online retailer Amazon (NASDAQ:AMZN) met Wall Street’s revenue expectations in Q3 2026, with revenue rising 12.1% year on year to $201.9 ...

Record refining margins and production growth drove a 50% surge in net income.

X4 Pharmaceuticals (NASDAQ:XFOR) said it expects to complete enrollment in its pivotal Phase III 4WARD trial of mavorixafor for primary chronic neutropenia, or PCN, by the end of the fourth quarter of 2026, with top-line data anticipated in the first quarter of 2028. Executive Chairman Adam Craig s

Pagaya Technologies (NASDAQ:PGY) reported record third-quarter GAAP net income of nearly $50 million as network volume rose 29% year over year to $3.6 billion and the company maintained largely flat operating expenses. Chief Executive Officer Gal Krubiner said the company’s cost discipline helped i

Grupo Aeroportuario del Centro Norte (NASDAQ:OMAB) reported higher passenger traffic, revenue and adjusted EBITDA in the third quarter of 2026, supported by tariff adjustments, commercial activity and cargo operations. OMA served 7.7 million passengers during the quarter, up 1.3% from a year earlie

Mobileye Global (NASDAQ:MBLY) reported third-quarter revenue of $492 million, down about 2% from $504 million a year earlier, while adjusted operating income rose 20% to $89 million. The advanced driver-assistance technology company said EyeQ shipment demand continued to exceed expectations, helping

NextDecade (NASDAQ:NEXT) said construction of its Rio Grande LNG project remained on budget and ahead of schedule in the third quarter, as the company narrowed its timing outlook for first liquefied natural gas production from Train 1 to the second quarter of 2027. Chairman and Chief Executive Offi

NovoCure (NASDAQ:NVCR) reported third-quarter 2026 net revenue of $193 million, up 16% from a year earlier, as growth in its Optune Gio business and an expanding launch of Optune Lua in Japan helped lift active patient counts to a record level. The company also raised its full-year revenue and adjus